Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $402.6200 (-0.96%) ($400.1900 - $409.9450) on Tue. Oct. 31, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 8 | Latest Price | $402.6200(-0.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | Weekly Trend | REGN declines -4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) QQQ(43%) XBI(43%) | Factors Impacting REGN price | REGN will decline at least -0.835% in a week (0% probabilities). UUP(-10%) VIXM(-7%) TLT(-6%) TIP(-1%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
Resistance Level | $437.79 | 5 Day Moving Average | $411.27(-2.1%) | 10 Day Moving Average | $422.07(-4.61%) | 20 Day Moving Average | $437.79(-8.03%) | To recent high | -20.1% | To recent low | 0% | Market Cap | $42.689b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |